Dr. Agarwal's Health Care Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
All promoters and promoter group entities of Dr. Agarwal's Health Care — including Dr. Amar Agarwal, Dr. Anosh Agarwal, Dr. Ashar Agarwal, Dr. Ashvin Agarwal, Dr. Adil Agarwal, Dr. Athiya Agarwal, their respective family trusts, and Dr. Agarwal's Eye Institute (partnership and private limited) — have filed the annual Regulation 31(4) declaration with BSE and NSE. Each one confirms that they, along with persons acting in concert, have not created any new encumbrance (pledge, lien, or similar charge) on their equity shares in the company beyond what was already disclosed during FY 2025–26. The filings were digitally signed on April 6, 2026, and are routine annual compliance submissions required by SEBI's takeover regulations.
This is a routine compliance filing with no material impact on the stock. It simply confirms promoters have not newly pledged or encumbered their holdings, which is mildly reassuring for shareholders as it indicates no sudden fundraising or margin pressure at the promoter level.